For aseptic processing the requirements of Annex 1 are clear – continuous monitoring. However, what about support rooms and the other areas of the facility where a product is made? How should monitoring frequencies for non-sterile areas be approached?

In this webinar, we consider:

•    Risk based approaches to environmental monitoring 
•    The key factors that influence monitoring frequencies
•    How to set a risk based approach for monitoring frequencies
•    How to applying risk based methods to reduce the number of samples taken within a room
•    How things can go wrong and what makes for a poor risk assessment

Click here to view on-demand. 

Designing a contamination control strategy is central to the revision to EU GMP Annex 1. But how should this be approached? During this webinar, we explore the elements you need to consider when building a contamination control strategy. This includes designing a strategy that is holistic, interlined, and relevant.

A contamination control strategy is a system that considers all the integral elements of pharmaceutical product manufacturing. This is best achieved using quality risk management principles and supporting risk assessments for contamination control and monitoring (detectability of contamination event). This webinar presents the fundamentals of such a strategy.

Topic areas we cover include:

• Microbial contamination
• Cleaning and disinfection
• Sterility assurance
• Facility design
• Chemical and particle contamination
• Other forms of contamination that can arise from mix-ups, damaging primary or secondary packaging, distribution problems, and environmental fluctuations

Click here to view on-demand. 

The environment in which products are processed or within which the sterility test is conducted must be designed in such a way that the risk of contamination is minimised. The environment is designed to prevent cross-contamination, from the environment or from the operator, from occurring. The isolator provides the optimal means to achieve this.

However, poorly designed and maintained isolators can themselves be sources of contamination, arising from poorly executed decontamination cycles to leaks from gauntlets.

Microbiologist and sterility expert Dr Tim Sandle joins RSSL Sterile Manufacture Lead Annette Russell to explore the elements you need to consider when designing, qualifying and operating isolators.

Topic areas we cover include:

• Isolator design and testing
• Air and particulate control
• Developing the best qualification approach
• Fragility of vapour disinfection of isolators
• Prerequisite tests for effective isolator operation
• Vulnerability of isolator gloves and gauntlets
• Qualifying isolators with chemical and biological indicators
• Troubleshooting isolator operational problems

Click here to view on-demand. 

The revision to EU GMP Annex 1 calls for an environmental monitoring programme that is proactive, and risk based. The use of a simple ‘one size fits all’ approach to monitoring is no longer relevant.

This includes addressing issues like pre- and post-shutdown assessments of facility environments; selecting monitoring locations by risk assessment; addressing concerns with cleaning and disinfection; and adapting programmes for ageing facilities.

Microbiologist and sterility expert Dr Tim Sandle joins RSSL Sterile Manufacture Lead Annette Russell to explore the elements you need to consider when fine tuning the environmental monitoring programme.

Topic areas we cover include:

• Contamination sources and vectors of contamination
• Linking environmental monitoring to change control
• Introducing risk based thinking to environmental monitoring sample selection and frequency determinations
• Going beyond the standards
• Linking monitoring to cleaning and disinfection
• Using rapid microbiological methods appropriately
• Connecting monitoring to facility maintenance
• Linking monitoring to shutdowns
• Tracking and trending microorganisms
• Setting appropriate limits

Click here to view on-demand. 

To avoid cross-contamination between different products and to remove residues and microorganisms, cleaning validation plays a central part in any pharmaceutical facility’s contamination control programme.

An effective approach to cleaning validation will be risk-based. A cleaning process has to be considered as any other process, for which critical process parameters have to be defined.

Microbiologist and sterility expert Dr Tim Sandle joins RSSL Sterile Manufacture Lead Annette Russell to explore the elements you need to consider when putting together a cleaning validation strategy. 

Topic areas we cover include:

• Critical Process Parameters (CPPs) for cleaning
• Critical Quality Attributes (CQAs) for cleaning
• Pre-requisites to begin cleaning validation
• Introducing risk-based thinking into the cleaning validation process
• Product and material groupings
• Assessing hold times
• Microbial attachment and removal
• Selecting optimal analytical test methods
• Why cleaning validation fails

Click here to view on-demand.